Pandemic’s silver lining
The intense international focus on the COVID-19 pandemic has provided a unique opportunity to use a wide array of novel tools to carry out scientific studies on the SARS-CoV-2 virus. The value of these comparative studies extends far beyond their consequences for SARS-CoV-2, providing broad implicat...
| Published in: | mAbs |
|---|---|
| Main Authors: | Fortunato Ferrara, Sara D’Angelo, M. Frank Erasmus, André A. Teixeira, Camila Leal-Lopes, Laura P. Spector, Tom Pohl, Adeline Fanni, Simon Cocklin, Andrew R. M. Bradbury |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2022.2133666 |
Similar Items
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance
by: M. Frank Erasmus, et al.
Published: (2023-12-01)
by: M. Frank Erasmus, et al.
Published: (2023-12-01)
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
by: Andre Azevedo Reis Teixeira, et al.
Published: (2021-01-01)
by: Andre Azevedo Reis Teixeira, et al.
Published: (2021-01-01)
Developing drug-like single-domain antibodies (VHH) from in vitro libraries
by: M. Frank Erasmus, et al.
Published: (2025-12-01)
by: M. Frank Erasmus, et al.
Published: (2025-12-01)
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability
by: Fortunato Ferrara, et al.
Published: (2024-12-01)
by: Fortunato Ferrara, et al.
Published: (2024-12-01)
Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)
by: A. V. Onyan, et al.
Published: (2016-02-01)
Recombinant Antibodies against Mycolactone
by: Leslie Naranjo, et al.
Published: (2019-06-01)
by: Leslie Naranjo, et al.
Published: (2019-06-01)
Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies
by: Brian A. Baldo
Published: (2022-02-01)
by: Brian A. Baldo
Published: (2022-02-01)
Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery
by: Elnazalsadat Jafarzadeh Chehraghi, et al.
Published: (2025-04-01)
by: Elnazalsadat Jafarzadeh Chehraghi, et al.
Published: (2025-04-01)
Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)
by: Sedykh SE, et al.
Published: (2018-01-01)
Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children
by: Soo-Han Choi, et al.
Published: (2025-10-01)
by: Soo-Han Choi, et al.
Published: (2025-10-01)
Monoclonal antibody usage pattern in a tertiary care center: A retrospective study
by: Shruthi Sridhar, et al.
Published: (2024-08-01)
by: Shruthi Sridhar, et al.
Published: (2024-08-01)
Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
by: Brian Effer, et al.
Published: (2023-07-01)
by: Brian Effer, et al.
Published: (2023-07-01)
Risankizumab: Daily Practice Experience of High Need Patients
by: Alexandra M. G. Brunasso, et al.
Published: (2023-06-01)
by: Alexandra M. G. Brunasso, et al.
Published: (2023-06-01)
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines
by: Takahiro Anzai, et al.
Published: (2022-07-01)
by: Takahiro Anzai, et al.
Published: (2022-07-01)
Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01)
by: Stalin Bala, et al.
Published: (2020-01-01)
Bispecific antibodies and their use in applied research
by: Harshit Verma, et al.
Published: (2012-01-01)
by: Harshit Verma, et al.
Published: (2012-01-01)
Memory Consolidation and ARIA in Individuals Receiving Anti-amyloid Monoclonal Antibodies
by: Marc W. Haut, et al.
Published: (2026-05-01)
by: Marc W. Haut, et al.
Published: (2026-05-01)
Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01)
by: JIN Ren-yao, et al.
Published: (2006-11-01)
MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS
by: G. V. Kuklina, et al.
Published: (2017-06-01)
by: G. V. Kuklina, et al.
Published: (2017-06-01)
Late killing of Plasmodium berghei sporozoites in the liver by an anti-circumsporozoite protein antibody
by: Manuela C Aguirre-Botero, et al.
Published: (2025-02-01)
by: Manuela C Aguirre-Botero, et al.
Published: (2025-02-01)
Serological and molecular characterization of Syrian <em>Tomato spotted wilt virus</em> isolates
by: Faiz ISMAEIL, et al.
Published: (2015-04-01)
by: Faiz ISMAEIL, et al.
Published: (2015-04-01)
Assessment of immunity induced in mice by glycoproteins derived from different strains and species of Leishmania
by: Tânia Mara Pinto Dabés Guimarães, et al.
Published: (1996-02-01)
by: Tânia Mara Pinto Dabés Guimarães, et al.
Published: (1996-02-01)
Immunocytochemical Labelling of Haematological Samples Using Monoclonal Antibodies
by: Wendy N. Erber
Published: (2021-12-01)
by: Wendy N. Erber
Published: (2021-12-01)
Development and Characterization of New Species Cross-Reactive Anti-Sialoadhesin Monoclonal Antibodies
by: Marjorie De Schryver, et al.
Published: (2016-03-01)
by: Marjorie De Schryver, et al.
Published: (2016-03-01)
The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
by: Juranić Zorica D., et al.
Published: (2002-01-01)
by: Juranić Zorica D., et al.
Published: (2002-01-01)
Sistema analítico de evaluación de la actividad biológica del reactivo hemoclasificador HEMO-CIM ANTI-A Analytical system of evaluation of the biological activity of anti-A hemo-cim hemoclassifier reagent
by: Lilia Suárez Batista, et al.
Published: (2000-08-01)
by: Lilia Suárez Batista, et al.
Published: (2000-08-01)
Prospective effect of linkers type on the anticancer activity of pemetrexed-monoclonal antibody (atezolizumab) conjugates [version 2; peer review: 2 approved, 1 approved with reservations]
by: Nidhal K. Maraie, et al.
Published: (2024-03-01)
by: Nidhal K. Maraie, et al.
Published: (2024-03-01)
Production of monoclonal antibody specific to surface antigen on hepatocellular carcinoma cell lines
by: Pawaraid On-Tong, et al.
Published: (2011-01-01)
by: Pawaraid On-Tong, et al.
Published: (2011-01-01)
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
by: Patrick M. Glassman, et al.
Published: (2014-03-01)
by: Patrick M. Glassman, et al.
Published: (2014-03-01)
Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN
by: Mika K. Kaneko, et al.
Published: (2017-02-01)
by: Mika K. Kaneko, et al.
Published: (2017-02-01)
Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs
by: Slava Stamova, et al.
Published: (2012-07-01)
by: Slava Stamova, et al.
Published: (2012-07-01)
The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
by: Daniela Luz, et al.
Published: (2021-11-01)
by: Daniela Luz, et al.
Published: (2021-11-01)
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates
by: Ami Patel, et al.
Published: (2024-12-01)
by: Ami Patel, et al.
Published: (2024-12-01)
Radiolabeled Human Serum Albumin Nanoparticles Co-Loaded with Methotrexate and Decorated with Trastuzumab for Breast Cancer Diagnosis
by: Meliha Ekinci, et al.
Published: (2023-09-01)
by: Meliha Ekinci, et al.
Published: (2023-09-01)
Distribution of tetraspanin family protein CD9 in bull reproductive system
by: P. Cupperová, et al.
Published: (2014-03-01)
by: P. Cupperová, et al.
Published: (2014-03-01)
Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
by: Kevin E. Ramos, et al.
Published: (2024-07-01)
by: Kevin E. Ramos, et al.
Published: (2024-07-01)
A Review of the Biology of Chikungunya Virus Highlighting the Development of Current Novel Therapeutic and Prevention Approaches
by: Geovana Martelossi-Cebinelli, et al.
Published: (2025-10-01)
by: Geovana Martelossi-Cebinelli, et al.
Published: (2025-10-01)
PREPARATION AND PROPERTIES OF MURINE ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES RECOGNIZING PRIMARY RABBIT POLYCLONAL ANTIBODIES AGAINST MORPHINE DERIVATIVES
by: A. V. Trofimov, et al.
Published: (2019-12-01)
by: A. V. Trofimov, et al.
Published: (2019-12-01)
Deep mutationally scanned CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies
by: Megan M. Stumpf, et al.
Published: (2025-04-01)
by: Megan M. Stumpf, et al.
Published: (2025-04-01)
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
by: Ahmed M. Khalil, et al.
Published: (2023-07-01)
by: Ahmed M. Khalil, et al.
Published: (2023-07-01)
Similar Items
-
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance
by: M. Frank Erasmus, et al.
Published: (2023-12-01) -
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
by: Andre Azevedo Reis Teixeira, et al.
Published: (2021-01-01) -
Developing drug-like single-domain antibodies (VHH) from in vitro libraries
by: M. Frank Erasmus, et al.
Published: (2025-12-01) -
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability
by: Fortunato Ferrara, et al.
Published: (2024-12-01) -
Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)
